Travere Therapeutics (NASDAQ:TVTX) is pursuing growth through expanded use of FILSPARI in rare kidney diseases while advancing a late-stage treatment candidate for classical homocystinuria and building its renal pipeline through the recently in-licensed BTK inhibitor civorebrutinib, Chief Financial
George S. Felix reduced his direct equity holdings following a 50% one-year stock return, retaining 6,293 directly held shares valued at $1.49 million.
Explore expert insights on Diabetes and Musculoskeletal Health Treatment in Delhi. Learn how diabetes can affect bones, joints, muscles, and overall mobili
The telecom industry is in the middle of one of its biggest infrastructure overhauls in decades. Operators that once ran everything on dedicated, hardware-
Businesses today can work with customers, suppliers, employees, and partners from different countries. This creates new opportunities, but it also introduc
Professional Teeth WhiteningA brighter smile is one of those cosmetic changes that can seem simple until you start comparing whitening products, treatments
Once seen as a niche pick for cold winter nights, stout is having a genuine moment. This dark, roasted-malt beer style is winning over a much wider audienc
A business opportunity can arrive quickly. A company may secure a new client, expand into a new market, or start a project that requires additional employe
The global recycled plastics market is entering a period of sustained expansion, driven by tightening plastic-waste regulations, growing corporate sustaina
A dependable heating system is essential for keeping your home warm and comfortable during cold weather. If your current furnace is outdated, inefficient,
